Indian Equity Markets Analyzed

Key Points

• The Nifty and Sensex declined in three consecutive trading sessions, falling 1.54% and 1.63% respectively.
• Volatility remained high as investors awaited the US Federal Reserve’s interest rate decision.
• Several IPOs saw strong subscription rates, indicating investor interest in new offerings.
• The Nifty Consumer Durables index faced significant declines, impacting specific stocks.
• Market breadth was negative, with more shares declining than rising.
• Positive news regarding infrastructure projects and regulatory approvals boosted some stocks.

Market Overview – December 10, 2025

Today’s trading session saw the Indian equity markets experience continued declines, marking a third consecutive downward trend. Investors were keenly observing developments ahead of the US Federal Reserve’s interest rate announcement, a pivotal moment influencing global markets. Trading was characterized by volatility as the expected decision loomed.

The Nifty 50 index settled at 25,758, dropping 81.65 points, while the S&P BSE Sensex decreased by 275.01 points, closing at 84,391.27. Several key indices reflected this overall downward pressure. The market’s focus remained centered on the anticipated Federal Reserve policy.

Sectoral performance was mixed. While media, metal, and pharma shares saw some gains, consumer durables, IT, and PSU bank stocks experienced losses. This divergence highlighted the varied impact of broader market sentiment on different sectors.

Several Initial Public Offerings (IPOs) were closely watched. The Aequs, Meesho, and Vidya Wires IPOs saw strong subscription rates, reflecting investor confidence in these companies. New listings offered potential upside, while the performance of existing IPOs provided insights into market demand.

Significant corporate developments also influenced trading. IRB Infrastructure Developers saw its stock rise following a positive announcement regarding toll revenue, indicating robust infrastructure activity. AU Small Finance Bank gained ground due to regulatory approval allowing increased foreign investment. Zydus Lifesciences’ launch of a biosimilar, Zyrifa, also contributed positively to investor sentiment.

Global markets mirrored the cautious tone, with European stocks trading lower, and Asian markets also experiencing declines. Investors were carefully monitoring China’s inflation data and awaiting the US Federal Reserve’s decision, which was largely expected to involve another 0.25% interest rate cut. The S&P 500 finished relatively flat, influenced by a decline in JPMorgan shares due to projected expenses.

Ultimately, today’s market performance underscored the importance of anticipating key economic events and their potential impact on investment strategies.